Which Key Market Drivers Are Expected To Shape The Growth Trajectory Of The Gynecomastia Procedures Market?
The gynecomastia procedures market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for outpatient cosmetic procedures, rising use of non-invasive energy-based devices, expansion of aesthetic medicine investments, growing focus on personalized treatment planning, increasing adoption of ultrasound-assisted procedures. Major trends in the forecast period include increasing preference for minimally invasive procedures, rising demand for cosmetic male health treatments, growing adoption of advanced liposuction techniques, expansion of non-surgical treatment options, enhanced focus on patient-centric outcomes.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24549&type=smp
What Significant Demand Drivers Are Anticipated To Influence The Gynecomastia Procedures Market Over The Coming Years?
The increasing prevalence of obesity is expected to propel the growth of the gynecomastia procedures market going forward. Obesity refers to a medical condition characterized by excessive body fat accumulation, often measured by a body mass index (BMI) of 30 or higher, which can lead to various health complications. The rise in obesity is due to increasing sedentary lifestyles, where a lack of physical activity and prolonged sitting contribute to weight gain and poor metabolic health. Gynecomastia procedures help address the condition of enlarged male breasts, which is often exacerbated by obesity, as excess fat tissue in the chest area can mimic or worsen the appearance of gynecomastia, making surgical intervention a beneficial solution. For instance, in March 2023, according to the World Heart Foundation, a Switzerland-based non-government organization, globally around 2.3 billion adults and children are obese or overweight, and with the current obesity trend, it is estimated that the number of people living with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is driving the growth of the gynecomastia procedures market.
What Segment Divisions Provide The Most Valuable Insights Into The Gynecomastia Procedures Market?
The gynecomastia procedures market covered in this report is segmented –
1) By Procedure Type: Liposuction, Mastectomy, Thyroid Hormone Therapy, Medications, Ultrasound
2) By Age Group: Adolescents, Adults, Elderly
3) By End-User: Hospitals, Cosmetic Surgery Centers, Other End-Users
Subsegments:
1) By Liposuction: Tumescent Liposuction, Ultrasound-Assisted Liposuction, Power-Assisted Liposuction, Laser-Assisted Liposuction
2) By Mastectomy: Subcutaneous Mastectomy, Bilateral Mastectomy, Nipple-Sparing Mastectomy
3) By Thyroid Hormone Therapy: Synthetic Thyroid Hormones, Natural Desiccated Thyroid, Combination Therapy
4) By Medications: Anti-Estrogen Medications, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs)
5) By Ultrasound: High-Intensity Focused Ultrasound (HIFU), Low-Intensity Focused Ultrasound, Acoustic Wave Therapy
What Current Industry Trends Are Affecting The Performance Of The Gynecomastia Procedures Market?
Major companies operating in the gynecomastia procedures market are focusing on advanced innovations such as non-invasive cures to reduce surgical risks, improve patient outcomes, and address the unmet medical need for safer, more effective treatments. A non-invasive cure refers to a treatment that avoids surgery by using oral medications or external therapies to address conditions like gynecomastia without the need for incisions or anesthesia. For instance, in June 2024, BioZen Limited, a UK-based biotechnology company, introduced a groundbreaking daily pill regimen designed to cure gynecomastia. This proprietary dual-therapy formulation combines a low dose of tamoxifen (TAM) with indole-3-carbinol (I3C), a naturally occurring compound derived from cruciferous vegetables, delivered as a convenient once-daily oral medication. Preclinical data from BioZen suggest that this dual approach can holistically reverse the hormonal imbalance driving gynecomastia, potentially offering a safe, effective, and scalable alternative to surgery.
Who Are The Key Companies Actively Operating Within The Gynecomastia Procedures Market?
Major companies operating in the gynecomastia procedures market are Spire Healthcare Group plc, InMode Ltd., Lumenis Ltd., Cynosure LLC, Max Healthcare Institute Limited, Alma Lasers Ltd., Pristyn Care Private Limited, Cutera Inc., Solta Medical Inc., Erchonia Corporation, MicroAire Surgical Instruments LLC, Allure Medspa, Florida Plastic Surgery Group P.A., The Aesthetica, Austin Gynecomastia Center, Apyx Medical Corporation
Get Your In-Depth Gynecomastia Procedures Market Report Now:
https://www.thebusinessresearchcompany.com/report/gynecomastia-procedures-global-market-report
Which Regions Are Projected To Advance The Fastest Over The Forecast Horizon In The Gynecomastia Procedures Market?
North America was the largest region in the gynecomastia procedures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gynecomastia procedures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment